MedTrace Logo

Comparison of Conventional Dose Regimen and New Dose Regimen of Pregabalin

NCT03691038 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-09-04

No results posted yet for this study

Summary

The purpose of this study is to propose a new flexible dose regimen starting from 75mg using the low dose pregabalin 25 mg and 50 mg comparing the side effect and compliance with the conventional flexible dose regimen staring from 150mg using the pregabalin 75mg.

Conditions

  • Pain, Neuropathic

Interventions

DRUG

Pregabalin 75mg bid

Through the study period, Incremental protocol follows the conventional dose regimen starting pregabaline 75mg bid.

DRUG

Pregabalin 25mg, 50mg

Through the study period, Incremental protocol follows the new dose regimen starting pregabalin 25mg, 50mg

Sponsors & Collaborators

  • Kangbuk Samsung Hospital

    lead OTHER

Principal Investigators

  • Sung Hyun Lee, MD · Kangbuk Samsung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2019-10-30
Completion
2019-10-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691038 on ClinicalTrials.gov